Analyzing Consecutive Intravesical Gem/Doce for Untreated and Previously Treated Intermediate-Risk NMIBC
Physician's Weekly,
The following is a summary of “Sequential intravesical gemcitabine and docetaxel for treatment-naïve and previously treated…
Sequential intravesical gemcitabine and docetaxel for treatment-naïve and previously treated intermediate-risk nonmuscle invasive bladder cancer
Overview of attention for article published in Urologic Oncology, July 2023
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (88th percentile)
-
High Attention Score compared to outputs of the same age and source (86th percentile)
Readers on
- mendeley
- 17 Mendeley